1242657

David Mercer, M.D. — FEI 3030463621

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Omaha, NE (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance